![]() | <img alt="" height="1" width="1" />Anthera IPO: Second Biotech to Price Low, but Price Isn't EverythingBNETIronwood is in Phase III with a drug for constipation and irritable bowel syndrome, while Anthera is preparing for a Phase III in acute coronary syndrome. ...<nobr>and more »</nobr> |